Comparison of the effect of orally administered soluble β-(1-3),(1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis

In Vivo

Volumn 24, Issue 1, 2010, Pages 59-63

  Harnack, Ulf ^a   Eckert, Klaus ^b   Fichtner, Iduna ^b   Pecher, Gabriele ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Cyclophosphamide; G CSF; Granulopoiesis; Hematopoiesis; Monocyte; Glucan

Indexed keywords

BETA 1,3 GLUCAN; BETA 1,6 GLUCAN; CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; FEMALE; GRANULOCYTE; GRANULOPOIESIS; HEMATOPOIESIS; LEUKOCYTE COUNT; MONOCYTE; MOUSE; NONHUMAN;

EID: 77649097773     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kobayashi Y, Okabe T, Urabe A, Suzuki N and Takaku F: Human granulocyte colony-stimulating factor produced by Escherichia coli shortens the period of granulocytopenia induced by irradiation in mice. Jpn J Cancer Res 78: 763-766, 1987.
2. Coutinho LH, Will A, Radford J, Schiró R, Testa NG and Dexter TM: Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture. Blood 75: 2118-2129, 1990.
3. Lord BI, Molineux G, Pojda Z, Souza LM, Mermod JJ and Dexter TM: Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood 77: 2154-2159, 1991.
4. Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D and Fox R: Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet I: 667-672, 1988.
5. Laughlin M.J, Kirkpatrick G, Sabiston N, Peters W and Kurtzberg J: Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF. Ann Hematol 67: 267-276, 1993.
6. Burgaleta C and Golde DW: Effect of glucan on granulopoiesis and macrophage genesis in mice. Cancer Res 37: 1739-1742, 1977.
7. Patchen ML and MacVittie TJ: Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice. Int J Immunopharmacol 7: 923-932, 1985.
8. Hashimoto K, Suzuki I, Ohsawa M, Oikawa S and Yadomae T: Enhancement of hematopoietic response of mice by intraperitoneal administration of a beta-glucan SSG, obtained from Sclerotinia sclerotiorum. J Pharmacobiodyn 13: 512-517, 1990.
9. Ohno N, Miura NN, Nakajima M and Yadomae T: Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull 23: 866-872, 2000.
10. Tateishi T, Ohno N, Adachi Y and Yadomae T: Increases in hematopoietic responses caused by beta-glucans in mice. Biosci Biotechnol Biochem 61: 1548-1553, 1997.
11. Vetvicka V, Dvorak B, Vetvickova J, Richter J, Krizan J, Sima P and Yvin JC: Orally administered marine (1→3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity. Int J Biol Macromol 40: 291-298, 2007.
12. Patchen ML, Liang J, Vaudrain T, Martin T, Melican D, Zhong S, Stewart M and Quesenberry PJ: Mobilization of peripheral blood progenitor cells by betafectin PGG-glucan alone and in combination with granulocyte colony-stimulating factor. Stem Cells 16: 208-217, 1998.
13. Patchen ML, MacVittie TJ, Solberg BD and Souza LM: Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor. Exp Hematol 18: 1042-1048, 1990.
14. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS and Gordon S: Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 197: 1119-1124, 2003.
15. Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L, Gordon S and Wong SYC: The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol 169: 3876-3882, 2002.
16. Cramer DE, Allendorf DJ, Baran JT, Hansen R, Marroquin J, Li B, Ratajzak J, Ratajzak MZ and Yan J: Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury. Blood 107: 835-840, 2006.
17. Hofer M, Pospisil M, Viklická S, Vacek A, Pipalová I and Bartonicková A: Hematopoietic recovery in repeatedly irradiated mice can be enhanced by a repeatedly administered combination of diclofenac and glucan. J Leukoc Biol 53: 185-189, 1993.
18. Harada T, Kawaminami H, Miura NN, Adachi Y, Nakajima M, Yadomae T and Ohno N: Mechanism of enhanced hematopoietic response by soluble beta-glucan SCG in cyclophosphamide-treated mice. Microbiol Immunol 50: 687-700, 2006.
19. Lin H, Cheung SWY, Nesin M, Cassileth BR and Cunningham-Rundles S: Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production. Clin Vaccine Immunol 14: 21-27, 2007.
20. Demir G, Klein HO, Mandel-Molinas N and Tuzuner N: Beta-glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. Int Immunopharmacol 7: 113-116,2007.
21. Weitberg AB: A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy. J Exp Clin Cancer Res 27: 40, 2008.
22. Shalit I, Kletter Y, Halperin D, Waldman D, Vasserman E, Nagler A and Fabian I: Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia. Eur J Haematol 66: 287-296, 2001.
23. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung N-KV and Ross GD: Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 173: 797-806, 2004.
24. Lord BI, Lorna BW and Molineux G: Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/OI (PEG-r-metHu G-CSF). Clin Cancer Res 7: 2085-2090, 2001.
25. Harada T, Miura N, Adachi Y, Nakajima M, Yadomae T and Ohno N: Effect of SCG, 1,3-beta-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide-induced leukopenic mice. Biol Pharm Bull 25: 931-939, 2002.